Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: Analysis of 65 cases

National Medical Journal of China

Volumn 87, Issue 11, 2007, Pages 721-724

  Hu, Wei Hong ^a   Qiao, Jie ^a   Li, Mei Zhi ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Insulin resistance; Monocyte chemoattractant protein 1; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROLACTIN; TESTOSTERONE;

ADULT; AMENORRHEA; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY MASS; CHEMOLUMINESCENCE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; OBESITY; OVARY FOLLICLE CELL; OVARY POLYCYSTIC DISEASE; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; TESTOSTERONE BLOOD LEVEL;

ADULT; BODY MASS INDEX; CHEMOKINE CCL2; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; LUTEINIZING HORMONE; OBESITY; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE;

EID: 34249796408     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary sypdrome in unselected black and white women of south eastern United States: a prospective study. J Clin Endocrinol Metab,1998,83:3078-3082.
2. Chinese source.
3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic ccritetia and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 2004,81:19-22.
4. Baldwin AS. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest, 2001,107:3-6.
5. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA, 2003, 100:7265-7270.
6. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes Relat Metab Disord, 2005, 29:146-150.
7. Terkeltaub R, Boisvert WA, Curtiss LK. Chemokines and atherosclerosis. Curr Opin Lipido, 1998, 9: 397-405.
8. Dahiman I, Kaaman M, Olsson T, et al. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab,2005,90:5834-5840.
9. Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell, 1998, 2:275-281.
10. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature, 1998,394:894-897.
11. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl Acad Sci USA, 2003, 100:7265-7270.
12. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α direct role in obesity-linked insulin resistance. Science, 1993, 259:87-91.
13. Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest, 1995,95:2409-2415.
14. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab, 1998, 83:847-850.
15. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest, 2003,112:1796-1808.
16. Xu HY,Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the develop- ment of obesity-related insulin resistance. J Clin Invest, 2003,112:1821-1830.
17. Arici A, Oral E, Bukulmez O, et al. Monocyte chemotactic protein-1 expression in human preovu -latory follicles and ovarian cells. J Reprod Immuno, 1997,32:201-219.
18. Stork S, Baumann K, von Schacky C, et al. Effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women. Cardiovasc Res,2002,53:642-649.
19. Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 1989, 38:1165-1174.